Emerging Viral Diagnostics (HK) Limited, EVDL, is a biotechnology company focuses on research, development and commercialization of products and services based on genetics and molecular biology. The management team of our company comprises deep experienced biotechnology experts and business professionals from around the world. Our core business includes research translation and new innovation in medical diagnostics and emerging diseases.
* A member of Avalon biomedical Group
Company Details
- Employees
- 19
- Address
- 25 Chong Yip St, Kwun Tong District,hong Kong
- Industry
- Biotechnology
- Website
- https://www.emvdl.com
- HQ
- Kwun Tong District
- Competitors
- EVDL, PanopticAI, Lee Kee Group, HKSTP - Hong Kong Science and Technology Parks Corporation, Avalon SteriTech, ITPR - Institute for Innovation, Translation and Policy Research @HKBU, Hestia Technology, NEYROBLASTGX LLC, Microbiota I-Center (MagIC) (香港微生物菌群創新中心), Gleneagles Hospital Hong Kong.
Emerging Viral Diagnostics (Hk) Limited Questions
Emerging Viral Diagnostics (Hk) Limited's website is https://www.emvdl.com
Emerging Viral Diagnostics (Hk) Limited's LinkedIn profile is https://hk.linkedin.com/company/emerging-viral-diagnostics-hk-limited
Emerging Viral Diagnostics (Hk) Limited has
19 employees.
View email and phone details for 19
employees at Emerging Viral Diagnostics (Hk) Limited.
Emerging Viral Diagnostics (Hk) Limited's industry is
Biotechnology
Emerging Viral Diagnostics (Hk) Limited's top competitors are
Evdl,
Panopticai,
Lee Kee Group,
Hkstp - Hong Kong Science And Technology Parks Corporation,
Avalon Steritech,
Itpr - Institute For Innovation, Translation And Policy Research @hkbu,
Hestia Technology,
Neyroblastgx Llc,
Microbiota I-Center (Magic) (香港微生物菌群創新中心),
Gleneagles Hospital Hong Kong.
Emerging Viral Diagnostics (Hk) Limited's categories are Biotechnology
